Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture

This paper demonstrates multiple benefits of intravitreal bevacizumab (IVB) on diabetic retinopathy (DR) including diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR) at 24 months of followup. This is a retrospective multicenter interventional comparative case series of intravi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Arevalo, J. Fernando, Sanchez, Juan G., Lasave, Andres F., Wu, Lihteh, Maia, Mauricio, Bonafonte, Sergio, Brito, Miguel, Alezzandrini, Arturo A., Restrepo, Natalia, Berrocal, Maria H., Saravia, Mario, Farah, Michel Eid, Fromow-Guerra, Jans, Morales-Canton, Virgilio
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi Publishing Corporation 2011
Aiheet:
Review Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3090772/
https://ncbi.nlm.nih.gov/pubmed/21584260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/584238
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia